Protein FDR Confidence: CombinedAccessionDescriptionExp. q-value: CombinedSum PEP ScoreCoverage [%]# Peptides# PSMs# Unique Peptides# AAsMW [kDa]calc. pI# Peptides (by Search Engine): A2 Sequest HT (IgG)# Peptides (by Search Engine): B2 Sequest HT (Sel1L)# Peptides (by Search Engine): C2 Sequest HT (WT)# Peptides (by Search Engine): D2 Sequest HT (HKO)# PSMs (by Search Engine): A2 Sequest HT (IgG)# PSMs (by Search Engine): B2 Sequest HT (Sel1L)# PSMs (by Search Engine): C2 Sequest HT (WT)# PSMs (by Search Engine): D2 Sequest HT (HKO)Abundance: F1: Sample, IgGAbundance: F2: Sample, Sel1LAbundance: F3: Sample, WTAbundance: F4: Sample, HKOAbundances Count: F1: Sample, IgGAbundances Count: F2: Sample, Sel1LAbundances Count: F3: Sample, WTAbundances Count: F4: Sample, HKOModificationsBiological ProcessCellular ComponentMolecular FunctionPfam IDsEntrez Gene IDEnsembl Gene IDGene SymbolChromosomeReactome PathwaysKEGG Pathways# Razor Peptides
HighP06756Integrin alpha-V OS=Homo sapiens OX=9606 GN=ITGAV PE=1 SV=204.306222210481165.6822692126.21882cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process;regulation of biological process;response to stimulus;transportcell surface;cytosol;membranemetal ion binding;protein binding;receptor activity;signal transducer activity;transporter activity"Pf01839, Pf08441, Pf13517"3685ENSG00000138448.11ITGAV2Integrin cell surface interactions; Signal transduction by L1; PECAM1 interactions; Cross-presentation of particulate exogenous antigens (phagosomes); VEGFA-VEGFR2 Pathway; Molecules associated with elastic fibres; Syndecan interactions; ECM proteoglycans; Laminin interactions; Neutrophil degranulationArrhythmogenic right ventricular cardiomyopathy (ARVC); Dilated cardiomyopathy; Cell adhesion molecules (CAMs); Pathways in cancer; Thyroid hormone signaling pathway; Phagosome; Focal adhesion; Proteoglycans in cancer; Regulation of actin cytoskeleton; Small cell lung cancer; ECM-receptor interaction; PI3K-Akt signaling pathway; Hypertrophic cardiomyopathy (HCM)0

[View entry in the full dataset]